Trials / Completed

CompletedNCT00002084

A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients

Status: Completed
Phase: N/A
Study type: Interventional
Enrollment: —

Sponsor: Glaxo Wellcome · Industry
Sex: All
Age: 18 Years
Healthy volunteers: Not accepted

Summary

To determine the safety and efficacy of oral valacyclovir hydrochloride ( 256U87 ) compared to acyclovir in the treatment of recurrent anogenital herpes in HIV-infected patients with CD4 counts = or \> 100 cells/mm3.

Conditions

Herpes Simplex
HIV Infections

Interventions

Type	Name	Description
DRUG	Valacyclovir hydrochloride
DRUG	Acyclovir

Timeline

First posted: 2001-08-31
Last updated: 2005-06-24

Locations

46 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00002084. Inclusion in this directory is not an endorsement.